Analyst Ranking
Top 22%
#1151 out of 5266 analysts
Average Return
+11.19%
Win Rate
57%17 out of 30
Risk vs Reward
Poor
Good

Kyle Bauser's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ufp Technologies IncUFPT
+145.43%$78.60$192.91
2022-06-21 -
2023-06-21
Strong Buy
Performant Healthcare IncPHLT
+112.91%$3.64$7.75
2024-11-06 -
2025-10-21
Strong Buy
Spok Holdings IncSPOK
+97.31%$7.26$14.33
2022-09-22 -
2023-09-22
Strong Buy
Infusystem Holdings IncINFU
+80.35%$5.75$10.37
2025-07-21 -
2026-05-01
Strong Buy
Apyx Medical CorpAPYX
+77.84%$3.52$6.26
2022-05-19 -
2023-05-19
Strong Buy

Kyle Bauser's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
SNWV
3Strong Buy$47.00N/AReiterates
a month ago
Lemaitre Vascular IncLMAT
2Strong Buy$117.00+4.43%Reiterates
2 months ago
Infusystem Holdings IncINFU
3Strong Buy$15.00+44.65%Reiterates
2 months ago
Tactile Systems Technology IncTCMD
3Hold$32.00+39.80%Maintains
2 months ago
Nuo Therapeutics IncAURX
1Strong Buy$3.00+445.45%Initiates Coverage On
5 months ago
Apyx Medical CorpAPYX
3Strong Buy$6.00+96.08%Initiates Coverage On
5 months ago
Microbot Medical IncMBOT
1Strong Buy$5.50+161.90%Initiates Coverage On
5 months ago
Electromed IncELMD
5Strong Buy$36.00+40.63%Reiterates
6 months ago
Stereotaxis IncSTXS
2Strong Buy$4.00+107.25%Reiterates
6 months ago
Varex Imaging CorpVREX
3Strong Buy$16.00+37.81%Maintains
9 months ago
Bio Techne CorpTECH
1Strong Buy$65.00+18.14%Initiates Coverage On
10 months ago
Performant Healthcare IncPHLT
2Strong Buy$7.00N/AMaintains
a year ago
Spok Holdings IncSPOK
2Hold$15.00N/AInitiates Coverage On
2 years ago
Orchestra Biomed Holdings IncOBIO
1Strong Buy$15.00N/AInitiates Coverage On
2 years ago
Ufp Technologies IncUFPT
2Strong BuyN/AN/AInitiates Coverage On
4 years ago
Biolase IncBIOL
1Strong Buy$1,200.00N/AInitiates Coverage On
4 years ago
Streamline Health Solutions IncSTRM
2Strong Buy$45.00N/AInitiates Coverage On
4 years ago
Sientra IncSIENQ
1Strong Buy$80.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.